A method of decision analysis quantifying the effects of age and comorbidities on the probability of deriving significant benefit from medical treatments.

about

A method of decision analysis quantifying the effects of age and comorbidities on the probability of deriving significant benefit from medical treatments.

Item

http://www.wikidata.org/entity/Q51787522

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A method of decision analysis ...... nefit from medical treatments.

@en

A method of decision analysis ...... nefit from medical treatments.

@nl

type

Item

label

A method of decision analysis ...... nefit from medical treatments.

@en

A method of decision analysis ...... nefit from medical treatments.

@nl

prefLabel

A method of decision analysis ...... nefit from medical treatments.

@en

A method of decision analysis ...... nefit from medical treatments.

@nl

P1476

A method of decision analysis ...... nefit from medical treatments.

@en

P2093

Nigel G Bean

http://www.w3.org/2001/XMLSchema#string

Ravi P Ruberu

http://www.w3.org/2001/XMLSchema#string

Stephen P Fitzgerald

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of statins on average survival in randomised trials, an analysis of end point postponement

Managing comorbidities in COPD

Patient-accessible tool for shared decision making in cardiovascular primary prevention: balancing longevity benefits against medication disutility.

Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Validation of Clinical Classification Schemes for Predicting Stroke

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

P304

50-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15256/JOC.2017.7.93

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29090189

http://www.w3.org/2001/XMLSchema#string

P932

5556438

http://www.w3.org/2001/XMLSchema#string